adplus-dvertising
Connect with us

News

Canada's COVID-19 response better than many comparable countries, study finds – CBC News

Published

 on


Canada handled the first two years of the COVID-19 pandemic and weathered the ensuing upheaval better than several other nations with comparable health-care and economic infrastructure, a new study suggests.

The research, published in the Canadian Medical Association Journal on Monday, credits Canada’s strong performance to restrictive and persistent public health measures as well as a successful vaccination campaign.

A team of Ontario researchers compared data from February 2020 to February 2022 in 11 countries dubbed the G10 due to the late inclusion of one subject. They analyzed data from Canada, Belgium, France, Germany, Italy, Japan, the Netherlands, Sweden, Switzerland, the United Kingdom and the United States — all countries with similar political, economic, and health-care systems.

“If you look at Canada compared to the G10, the differences are enormous,” study co-author Dr. Fahad Razak said in a recent interview.

“If you look at our vaccination rate, we had the highest in the entire G10, we had the lowest number of people infected and lowest of people dying.”

The research suggests Canada’s cumulative per-capita rate of COVID-19 cases was 82,700 per million, while all countries — with the exception of Japan — were above 100,000 per million. Canada’s rate of COVID-19—related deaths was 919 per million, once again second-lowest behind Japan. All other countries were over 1,000 per million.

Raywat Deonandan, an epidemiologist and associate professor at the University of Ottawa who was not involved in the study, said the methodology of the research is sound, even if it can be challenging to compare infections and deaths across jurisdictions. 

“Bottom line: Canada’s relatively strict approach resulted in fewer infections and deaths,” Deonandan said in an email.

WATCH | Expert explains how Canada fared comparably well in the pandemic:

Canadian public health measures made ‘big difference’ against COVID-19, expert says

14 hours ago

Duration 5:01

A new study in the Canadian Medical Association Journal suggests Canada’s public health response to the COVID-19 pandemic was better than many similar countries. Montreal cardiologist Dr. Christopher Labos agrees, saying Canada did well when considering factors like mortality and vaccination rates.

‘Persistent level’ of restrictions

Razak said at least 70,000 more Canadians would have died during the first two years of the pandemic if Canada had the same death rates as the United States, the country with the highest cumulative number of COVID-19-related deaths.

“That means most of us would probably personally know a grandparent, or a friend or family member … who’s living today in Canada who would have died if we had the same trajectory as the United States,” Razak said.

He said Canada’s comparatively positive outcomes came about despite gaining access to vaccination later than most countries, noting there were also other health-care system structural disadvantages to overcome across the country at the outset of the pandemic.

A member of the Governor General’s Foot Guards wearing a mask waits on the red carpet at the Governor General’s Performing Arts Awards Gala in Ottawa on May 28. (Patrick Doyle/The Canadian Press)

“Some hospitals were so overwhelmed that we had to ambulance or airlift patients to other hospitals,” he said.

But Canada, he said, differed from other developed countries when it opted to implement public health measures that were both strict and persistent. Though such measures drew vehement opposition in some circles, Razak said they helped mitigate the pandemic’s overall impact.

“Compared to many other countries … they would have periods with tight restrictions but quickly pull back,” he said. “For Canada, it was really this high and persistent level almost entirely for the first two years.”

Highest proportion with two doses

Razak said the success of Canada’s immunization drive emerged as the strongest takeaway from the research, praising officials for engaging with the population and ensuring vaccines were readily available across the country.

More than 80 per cent of eligible Canadians have been fully vaccinated with two doses as of June. The percentage of the vaccinated populations in other G10 countries is between 64 and 77 per cent, according to the study.

“There was a magic in Canada around these vaccine roll-outs during dose one and dose two,” Razak said.

“When we speak to our colleagues across the world, Canada was the envy of the world in terms of our population rallying around this. It is a lesson to the world, that very high engagement can occur with the right strategy.”

Dr. Eleanor Fish, an immunology professor at the University of Toronto who was not involved in the study, said the findings were consistent with her own assessment of the pandemic in Canada. 

Like Razak, she said the population’s high vaccination rate played a major role in the country’s strong performance.

WATCH | Dr. Theresa Tam on timing of boosters:

COVID-19 boosters ‘likely’ needed around end of this year, Dr. Tam says

1 day ago

Duration 8:42

Canada’s chief public health officer, Dr. Theresa Tam, speaks to CBC chief political correspondent Rosemary Barton about where Canada is with COVID-19, her thoughts on vaccine boosters and what she’s watching for when cooler fall temperatures return

Fish also cautioned that there could be challenges ahead this fall, when COVID and other respiratory illnesses are likely to put a strain on the health-care system.

“We should be planning for that now,” said Fish.

Economic burden

The study also showed the countries’ response to the pandemic left an economic burden, with government debt rising for all countries and Canada registering one of the highest relative increases.

“We had these very significant economic impacts, we had very tight restrictions on our individual freedom which led to things like isolation … but we also had really among the best results in terms of controlling the impact of the virus,” Razak said.

“Was it worth it? That’s not a scientific question. That’s a values and morals and policies question.”

Adblock test (Why?)

728x90x4

Source link

Continue Reading

News

STD epidemic slows as new syphilis and gonorrhea cases fall in US

Published

 on

 

NEW YORK (AP) — The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic levels, according to federal data released Tuesday.

The numbers represented some good news about sexually transmitted diseases, which experienced some alarming increases in past years due to declining condom use, inadequate sex education, and reduced testing and treatment when the COVID-19 pandemic hit.

Last year, cases of the most infectious stages of syphilis fell 10% from the year before — the first substantial decline in more than two decades. Gonorrhea cases dropped 7%, marking a second straight year of decline and bringing the number below what it was in 2019.

“I’m encouraged, and it’s been a long time since I felt that way” about the nation’s epidemic of sexually transmitted infections, said the CDC’s Dr. Jonathan Mermin. “Something is working.”

More than 2.4 million cases of syphilis, gonorrhea and chlamydia were diagnosed and reported last year — 1.6 million cases of chlamydia, 600,000 of gonorrhea, and more than 209,000 of syphilis.

Syphilis is a particular concern. For centuries, it was a common but feared infection that could deform the body and end in death. New cases plummeted in the U.S. starting in the 1940s when infection-fighting antibiotics became widely available, and they trended down for a half century after that. By 2002, however, cases began rising again, with men who have sex with other men being disproportionately affected.

The new report found cases of syphilis in their early, most infectious stages dropped 13% among gay and bisexual men. It was the first such drop since the agency began reporting data for that group in the mid-2000s.

However, there was a 12% increase in the rate of cases of unknown- or later-stage syphilis — a reflection of people infected years ago.

Cases of syphilis in newborns, passed on from infected mothers, also rose. There were nearly 4,000 cases, including 279 stillbirths and infant deaths.

“This means pregnant women are not being tested often enough,” said Dr. Jeffrey Klausner, a professor of medicine at the University of Southern California.

What caused some of the STD trends to improve? Several experts say one contributor is the growing use of an antibiotic as a “morning-after pill.” Studies have shown that taking doxycycline within 72 hours of unprotected sex cuts the risk of developing syphilis, gonorrhea and chlamydia.

In June, the CDC started recommending doxycycline as a morning-after pill, specifically for gay and bisexual men and transgender women who recently had an STD diagnosis. But health departments and organizations in some cities had been giving the pills to people for a couple years.

Some experts believe that the 2022 mpox outbreak — which mainly hit gay and bisexual men — may have had a lingering effect on sexual behavior in 2023, or at least on people’s willingness to get tested when strange sores appeared.

Another factor may have been an increase in the number of health workers testing people for infections, doing contact tracing and connecting people to treatment. Congress gave $1.2 billion to expand the workforce over five years, including $600 million to states, cities and territories that get STD prevention funding from CDC.

Last year had the “most activity with that funding throughout the U.S.,” said David Harvey, executive director of the National Coalition of STD Directors.

However, Congress ended the funds early as a part of last year’s debt ceiling deal, cutting off $400 million. Some people already have lost their jobs, said a spokeswoman for Harvey’s organization.

Still, Harvey said he had reasons for optimism, including the growing use of doxycycline and a push for at-home STD test kits.

Also, there are reasons to think the next presidential administration could get behind STD prevention. In 2019, then-President Donald Trump announced a campaign to “eliminate” the U.S. HIV epidemic by 2030. (Federal health officials later clarified that the actual goal was a huge reduction in new infections — fewer than 3,000 a year.)

There were nearly 32,000 new HIV infections in 2022, the CDC estimates. But a boost in public health funding for HIV could also also help bring down other sexually transmitted infections, experts said.

“When the government puts in resources, puts in money, we see declines in STDs,” Klausner said.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

Source link

Continue Reading

News

World’s largest active volcano Mauna Loa showed telltale warning signs before erupting in 2022

Published

 on

 

WASHINGTON (AP) — Scientists can’t know precisely when a volcano is about to erupt, but they can sometimes pick up telltale signs.

That happened two years ago with the world’s largest active volcano. About two months before Mauna Loa spewed rivers of glowing orange molten lava, geologists detected small earthquakes nearby and other signs, and they warned residents on Hawaii‘s Big Island.

Now a study of the volcano’s lava confirms their timeline for when the molten rock below was on the move.

“Volcanoes are tricky because we don’t get to watch directly what’s happening inside – we have to look for other signs,” said Erik Klemetti Gonzalez, a volcano expert at Denison University, who was not involved in the study.

Upswelling ground and increased earthquake activity near the volcano resulted from magma rising from lower levels of Earth’s crust to fill chambers beneath the volcano, said Kendra Lynn, a research geologist at the Hawaiian Volcano Observatory and co-author of a new study in Nature Communications.

When pressure was high enough, the magma broke through brittle surface rock and became lava – and the eruption began in late November 2022. Later, researchers collected samples of volcanic rock for analysis.

The chemical makeup of certain crystals within the lava indicated that around 70 days before the eruption, large quantities of molten rock had moved from around 1.9 miles (3 kilometers) to 3 miles (5 kilometers) under the summit to a mile (2 kilometers) or less beneath, the study found. This matched the timeline the geologists had observed with other signs.

The last time Mauna Loa erupted was in 1984. Most of the U.S. volcanoes that scientists consider to be active are found in Hawaii, Alaska and the West Coast.

Worldwide, around 585 volcanoes are considered active.

Scientists can’t predict eruptions, but they can make a “forecast,” said Ben Andrews, who heads the global volcano program at the Smithsonian Institution and who was not involved in the study.

Andrews compared volcano forecasts to weather forecasts – informed “probabilities” that an event will occur. And better data about the past behavior of specific volcanos can help researchers finetune forecasts of future activity, experts say.

(asterisk)We can look for similar patterns in the future and expect that there’s a higher probability of conditions for an eruption happening,” said Klemetti Gonzalez.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

Waymo’s robotaxis now open to anyone who wants a driverless ride in Los Angeles

Published

 on

 

Waymo on Tuesday opened its robotaxi service to anyone who wants a ride around Los Angeles, marking another milestone in the evolution of self-driving car technology since the company began as a secret project at Google 15 years ago.

The expansion comes eight months after Waymo began offering rides in Los Angeles to a limited group of passengers chosen from a waiting list that had ballooned to more than 300,000 people. Now, anyone with the Waymo One smartphone app will be able to request a ride around an 80-square-mile (129-square-kilometer) territory spanning the second largest U.S. city.

After Waymo received approval from California regulators to charge for rides 15 months ago, the company initially chose to launch its operations in San Francisco before offering a limited service in Los Angeles.

Before deciding to compete against conventional ride-hailing pioneers Uber and Lyft in California, Waymo unleashed its robotaxis in Phoenix in 2020 and has been steadily extending the reach of its service in that Arizona city ever since.

Driverless rides are proving to be more than just a novelty. Waymo says it now transports more than 50,000 weekly passengers in its robotaxis, a volume of business numbers that helped the company recently raise $5.6 billion from its corporate parent Alphabet and a list of other investors that included venture capital firm Andreesen Horowitz and financial management firm T. Rowe Price.

“Our service has matured quickly and our riders are embracing the many benefits of fully autonomous driving,” Waymo co-CEO Tekedra Mawakana said in a blog post.

Despite its inroads, Waymo is still believed to be losing money. Although Alphabet doesn’t disclose Waymo’s financial results, the robotaxi is a major part of an “Other Bets” division that had suffered an operating loss of $3.3 billion through the first nine months of this year, down from a setback of $4.2 billion at the same time last year.

But Waymo has come a long way since Google began working on self-driving cars in 2009 as part of project “Chauffeur.” Since its 2016 spinoff from Google, Waymo has established itself as the clear leader in a robotaxi industry that’s getting more congested.

Electric auto pioneer Tesla is aiming to launch a rival “Cybercab” service by 2026, although its CEO Elon Musk said he hopes the company can get the required regulatory clearances to operate in Texas and California by next year.

Tesla’s projected timeline for competing against Waymo has been met with skepticism because Musk has made unfulfilled promises about the company’s self-driving car technology for nearly a decade.

Meanwhile, Waymo’s robotaxis have driven more than 20 million fully autonomous miles and provided more than 2 million rides to passengers without encountering a serious accident that resulted in its operations being sidelined.

That safety record is a stark contrast to one of its early rivals, Cruise, a robotaxi service owned by General Motors. Cruise’s California license was suspended last year after one of its driverless cars in San Francisco dragged a jaywalking pedestrian who had been struck by a different car driven by a human.

Cruise is now trying to rebound by joining forces with Uber to make some of its services available next year in U.S. cities that still haven’t been announced. But Waymo also has forged a similar alliance with Uber to dispatch its robotaxi in Atlanta and Austin, Texas next year.

Another robotaxi service, Amazon’s Zoox, is hoping to begin offering driverless rides to the general public in Las Vegas at some point next year before also launching in San Francisco.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending